Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Nowak

Showing results (1151-1160 of 1,216) with videos related to

Pageof 122
Sort By:
Cancer Discovery|April 7, 2019
Tissue-Specific Oncogenic Activity of KRAS<sup>A146T</sup>Emily J Poulin, Asim K Bera, Jia Lu, et al.
Cancer Causes & Control : CCC|May 10, 2019
Proceedings of the fourth international molecular pathological epidemiology (MPE) meetingPeter T Campbell, Christine B Ambrosone, Reiko Nishihara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2021
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic CancerKatelyn T Byrne, Courtney B Betts, Rosemarie Mick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 18, 2023
Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic CancerHarshabad Singh, Rachel B Keller, Kevin S Kapner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 28, 2018
Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatumLi Liu, Fred K Tabung, Xuehong Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2022
Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic CancerAndressa Dias Costa, Sara A Väyrynen, Akhil Chawla, et al.
British Journal of Cancer|October 6, 2017
Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survivalVicente Morales-Oyarvide, Douglas A Rubinson, Richard F Dunne, et al.
Cancer Cell|May 8, 2026
Dendritic cell redundancy enables priming of anti-tumor CD4<sup>+</sup> T cells in pancreatic cancerCourtney T S Kureshi, Michael J Walsh, Rakeeb Kureshi, et al.
Digestion|December 1, 2006
Use of sedation for routine diagnostic upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy Survey of National Endoscopy Society MembersS D Ladas, L Aabakken, J-F Rey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2021
Association of <i>Fusobacterium nucleatum</i> with Specific T-cell Subsets in the Colorectal Carcinoma MicroenvironmentJennifer Borowsky, Koichiro Haruki, Mai Chan Lau, et al.
Pageof 122

Showing results (1151-1160 of 1,216) with videos related to

Sort By:
Pageof 122
Cancer Discovery|April 7, 2019
Tissue-Specific Oncogenic Activity of KRAS<sup>A146T</sup>Emily J Poulin, Asim K Bera, Jia Lu, et al.
Cancer Causes & Control : CCC|May 10, 2019
Proceedings of the fourth international molecular pathological epidemiology (MPE) meetingPeter T Campbell, Christine B Ambrosone, Reiko Nishihara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2021
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic CancerKatelyn T Byrne, Courtney B Betts, Rosemarie Mick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 18, 2023
Oncogenic Drivers and Therapeutic Vulnerabilities in KRAS Wild-Type Pancreatic CancerHarshabad Singh, Rachel B Keller, Kevin S Kapner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 28, 2018
Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatumLi Liu, Fred K Tabung, Xuehong Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2022
Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic CancerAndressa Dias Costa, Sara A Väyrynen, Akhil Chawla, et al.
British Journal of Cancer|October 6, 2017
Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survivalVicente Morales-Oyarvide, Douglas A Rubinson, Richard F Dunne, et al.
Cancer Cell|May 8, 2026
Dendritic cell redundancy enables priming of anti-tumor CD4<sup>+</sup> T cells in pancreatic cancerCourtney T S Kureshi, Michael J Walsh, Rakeeb Kureshi, et al.
Digestion|December 1, 2006
Use of sedation for routine diagnostic upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy Survey of National Endoscopy Society MembersS D Ladas, L Aabakken, J-F Rey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2021
Association of <i>Fusobacterium nucleatum</i> with Specific T-cell Subsets in the Colorectal Carcinoma MicroenvironmentJennifer Borowsky, Koichiro Haruki, Mai Chan Lau, et al.
Pageof 122